Adrienne Watson, Ph.D.

Chief Science Officer | Therillume @ Recombinetics

jg81u861.31036x.0u.0@2u19lkxx79vq8.84u Sign up to see email

Known information

Is featured in GeneWorx Capital Webinar discussing the 'Power of the Pig' in finding the next generation of Cancer Therapies

About Recombinetics

Recombinetics specializes in animal gene editing, focusing on biomedical research, regenerative medicine, and animal agriculture, with a significant role in xenotransplantation through its merger with Makana Therapeutics.

Report inaccurate information

People similar to Adrienne Watson, Ph.D.

Marco Weinberg

Head of Research @ ReCode Therapeutics

Marco Weinberg is a distinguished molecular biologist and current Head of Research, known for his extensive experience in gene therapy and molecular biology across various prestigious roles and institutions.

Rocco Morelli

Chief Executive Officer @ Recombinetics

Tim Clarkson

@ Recombinetics